1. Home
  2. FNWB vs EQ Comparison

FNWB vs EQ Comparison

Compare FNWB & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

N/A

Current Price

$9.71

Market Cap

93.6M

Sector

Finance

ML Signal

N/A

Logo Equillium Inc.

EQ

Equillium Inc.

N/A

Current Price

$1.41

Market Cap

89.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FNWB
EQ
Founded
1923
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.6M
89.4M
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
FNWB
EQ
Price
$9.71
$1.41
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
★ $15.00
$8.56
AVG Volume (30 Days)
31.4K
★ 546.8K
Earning Date
10-26-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 36.00
N/A
EPS
★ 0.04
N/A
Revenue
$176,000.00
★ $41,095,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.91
N/A
P/E Ratio
$242.75
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$7.76
$0.76
52 Week High
$12.52
$3.54

Technical Indicators

Market Signals
Indicator
FNWB
EQ
Relative Strength Index (RSI) 29.73 27.74
Support Level $9.55 $1.05
Resistance Level $10.38 $2.55
Average True Range (ATR) 0.24 0.11
MACD -0.01 -0.02
Stochastic Oscillator 26.34 14.71

Price Performance

Historical Comparison
FNWB
EQ

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It offers various products and services, such as commercial business loans, multi-family real estate loans, auto and consumer loans, transaction accounts, savings and money market accounts, online banking services, etc., focused on the lending, deposit, and money movement needs of individuals, businesses and nonprofit organizations. The Group's operations are mainly focused on serving various communities in Washington State, U.S. Substantially all of its income is derived from a diverse base of commercial, mortgage, and consumer lending activities and investments.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: